Search Results

Immunotherapy has transformed melanoma treatment, with over half of advanced patients now surviving more than 10 years. (Wikimedia Commons)
Ankur Deka
3 min read
New research reveals that combining two immunotherapy drugs has significantly boosted long-term survival rates for advanced melanoma patients
A team of investigators to discover therapies for all subtypes of cutaneous melanoma, an aggressive form of skin cancer. (Representational image: Pixabay)
MBT Desk
2 min read
Virtually all cutaneous melanomas display genetic alterations that activate a cancer-driving pathway called MAPK. There is currently no FDA-approved options for treatment with MAPK-targeted drugs.
Melanoma is the most serious type of skin cancer. (Wikimedia Commons)
MBT Desk
3 min read
Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma
A black pigment growth is seen in the image.
MBT Desk
3 min read
Emphasizing Important Studies and Professional Opinions about Melanoma, Liver Disease, and Stroke Prevention.
A close-up image of brown patch on a patient's skin indicating melanoma.
MBT Desk
2 min read
Combination treatment triggers immune response and limits tumor growth in preclinical models.
UVA’s melanoma trial will evaluate the safety and effectiveness of focused sound waves for augmenting the benefits of immunotherapy. (Representational image: CDC phil)
MBT Desk
2 min read
Clinical Trial Latest in UVA’s Cutting-Edge Research With Emerging Technology for Melanoma
Read More
logo
Medbound
www.medboundtimes.com